Pemphigus Vulgaris
📧 Sign up to get email alerts when something new happens for Pemphigus Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Effect of Topical Insulin on Healing Rate of Pemphigus Lesions [Phase 2]
Phase 2 trial evaluating topical insulin to improve healing of pemphigus vulgaris lesions has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
A completed clinical trial evaluating Legit.Health Plus Support as a diagnostic aid for generalized pustular psoriasis and other skin condit…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders [Phase 2]
This Phase 2 trial evaluating a COVID-19 booster vaccine in autoimmune-disease non-responders was terminated, with results posted on 2025-08…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) [Phase 3]
A Phase 3 trial evaluating the long-term safety and efficacy of subcutaneous efgartigimod PH20 SC in adults with pemphigus vulgaris or pemph…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Comparing DCP and DAP for Pemphigus Vulgaris [Phase 4]
A Phase 4 trial comparing DCP and DAP for Pemphigus Vulgaris has completed, potentially informing comparative efficacy and safety between th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris
The study evaluates the efficacy and safety of an anti-CD20 monoclonal antibody combined with azathioprine and corticosteroids for Pemphigus…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) [Phase 3]
A Phase 3 study evaluating subcutaneous efgartigimod PH20 SC in adults with pemphigus vulgaris or foliaceus has completed and posted results…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Dexamethasone Solution and Dexamethasone in Mucolox™ [Phase 2]
Phase 2 trial updates for Dexamethasone Solution and Dexamethasone in Mucolox show completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris [Phase 2]
Phase 2 study of PRN1008 in adults with pemphigus vulgaris completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid [Phase 3]
Phase 3 trial update investigating ozonated olive oil for Pemphigus Vulgaris and Bullous Pemigoid; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV) [Phase 4]
Clinical trial update for abatacept in pemphigus vulgaris (Phase 4) evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus [Phase 1]
Phase 1 trial update for polyclonal regulatory T cells (PolyTregs) in pemphigus shows terminated study with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris [Phase 2]
Phase 2 clinical trial evaluating the efficacy of an interleukin-2 gargle for treating oral mucosa lesions in pemphigus vulgaris.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus [Phase 2]
Phase 2 trial assessing safety, pharmacodynamics, pharmacokinetics, and efficacy of ARGX-113 in patients with pemphigus vulgaris and pemphig…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris [Phase 2]
Phase 2 trial of VAY736 in Pemphigus Vulgaris has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus) [Phase 1, Phase 2]
A safety and dose-finding study of SYNT001 in pemphigus (vulgaris or foliaceus) was conducted in Phase 1/2 and subsequently terminated; resu…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV) [Phase 3]
Phase 3 trial comparing Rituximab to Mycophenolate Mofetil in Pemphigus Vulgaris has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris [Phase 3]
Phase 3 trial of ofatumumab for pemphigus vulgaris was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris [Phase 3]
Phase 3 long-term extension study of ofatumumab in pemphigus vulgaris was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus [Phase 2]
Phase 2 randomized trial evaluating intravenous immunoglobulin with or without cyclophosphamide for pemphigus vulgaris was terminated; resul…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris [Phase 2]
A Phase 2 study of Etanercept (Enbrel) for Pemphigus Vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Use of Infliximab for the Treatment of Pemphigus Vulgaris [Phase 2]
Phase 2 trial results evaluating infliximab for Pemphigus vulgaris have been completed and posted. The study was sponsored by NIAID and resu…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV) [Phase 3]
Phase 3 clinical trial evaluating mycophenolate mofetil (CellCept) with reduced corticosteroids in active pemphigus vulgaris; the study is c…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone [Phase 2]
Phase 2 randomized trial evaluating adding azathioprine to prednisolone versus placebo in pemphigus vulgaris; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-19Clinical Trial Update: Use of KC706 for the Treatment of Pemphigus Vulgaris [Phase 2]
A Phase 2 clinical trial evaluating KC706 for Pemphigus Vulgaris has completed.